<?xml version="1.0" encoding="UTF-8" ?> 
<root> 
<content type="str">Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) saw a large decline in short interest during the month of January. As of January 13th, there was short interest totalling 1,654,835 shares, a decline of 31.4% from the December 30th total of 2,413,050 shares. Approximately 12.7% of the company’s shares are sold short. Based on an average trading volume…</content> 
<sequenceId type="str">695198203442</sequenceId> 
<topics type="list"> 
<item type="dict"> 
<group type="str">Industry</group> 
<name type="str">Pharma industry news</name> 
</item> 
<item type="dict"> 
<group type="str">Finance</group> 
<name type="str">Finance latest</name> 
</item> 
</topics> 
<estimatedPublishedDate type="str">2017-01-29T07:42:08Z</estimatedPublishedDate> 
<title type="str">Aurinia Pharmaceuticals Inc (AUPH) Short Interest Down 31.4% in January</title> 
</root>